Corrigendum to "Programmed cell death in the lithium pilocarpine model: Evidence for NMDA receptor and ceramide-mediated mechanisms" [Brain Dev 30 (2008) 513-519] (DOI:10.1016/j.braindev.2008.01.002);Programmed cell death in the lithium pilocarpine model: Evidence for NMDA receptor and ceramide-mediated mechanisms

Brain and Development

Volumn 30, Issue 8, 2008, Pages 513-519

  Mikati, Mohamad A ^a   Rizk, Elias ^a   El Dada, Shirine ^a   Zeinieh, Michele ^a   Kurdi, Rana ^a   El Hokayem, Jimmy ^a   Rahmeh, Amal ^a   Kobeissi, Mohamad ^a   Azzam, Diana ^a   Usta, Julnar ^a   El Sabban, Marwan ^a   Dbaibo, Ghassan ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Apoptosis; Ceramide; Lithium pilocarpine; MK 801; NMDA receptor; Status epilepticus

Indexed keywords

CERAMIDE; DIZOCILPINE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PILOCARPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; EPILEPTIC STATE; FEMALE; HIPPOCAMPUS; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING;

EID: 47149106104     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.01.013     Document Type: Erratum

References (27)

1. Dbaibo G.S., El-Assaad W., Krikorian A., Liu B., Diab K., Idriss N.Z., et al. Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death. FEBS Lett 503 (2001) 7-12
2. Kroesen B.J., Pettus B., Luberto C., Busman M., Sietsma H., de Leij L., et al. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J Biol Chem 276 (2001) 13606-13614
3. Cutler R.G., Pedersen W.A., Camandola S., Rothstein J.D., and Mattson M.P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 52 (2002) 448-457
4. Mikati M.A., Abi-Habib R.J., El Sabban M.E., Dbaibo G.S., Kurdi R.M., Kobeissi M., et al. Hippocampal programmed cell death after status epilepticus: evidence for NMDA-receptor and ceramide-mediated mechanisms. Epilepsia 44 (2003) 282-291
5. Sankar R., Shin D.H., Liu H., Mazarati A., Pereira de Vasconcelos A., and Wasterlain C.G. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 18 (1998) 8382-8393
6. Santos N.F., Marques R.H., Correia L., Sinigaglia-Coimbra R., Calderazzo L., Sanabria E.R., et al. Multiple pilocarpine-induced status epilepticus in developing rats: a long-term behavioral and electrophysiological study. Epilepsia 41 Suppl 6 (2000) S57-S63
7. Hanon E., and Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10 (2001) 287-293
8. Nakamura T., Miyamoto O., Kawai N., Negi T., Itano T., and Nagao S. Long term activation of the glutamatergic system associated with N-methyl-d-aspartate receptors after postischemic hypothermia in gerbils. Neurosurgery 49 (2001) 706-714
9. Ormandy G.C., Jope R.S., and Snead III O.C. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp Neurol 106 (1989) 172-180
10. Mikati M.A., Kurdi R.M., Rahmeh A.A., Farhat F., Abu Rialy S., Lteif L., et al. Effects of creatine and cyclocreatine supplementation on kainate induced injury in pre-pubescent rats. Brain Inj 18 (2004) 1229-1241
11. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32 (1972) 281-294
12. Hirsch E., Baram T.Z., and Snead III O.C. Ontogenic study of lithium-pilocarpine-induced status epilepticus in rats. Brain Res 583 (1992) 120-126
13. Perry D.K., Bielawska A., and Hannun Y.A. Quantitative determination of ceramide using diglyceride kinase. Methods Enzymol 312 (2000) 22-31
14. Mikati M.A., El Hokayem J.A., and El Sabban M.E. Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10. Epilepsia 48 (2007) 175-181
15. Fujikawa D.G. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res 725 (1996) 11-22
16. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
17. Bittigau P., Sifringer M., and Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci 993 (2003) 103-114
18. Kaindl A.M., Asimiadou S., Manthey D., Hagen M.V., Turski L., and Ikonomidou C. Antiepileptic drugs and the developing brain. Cell Mol Life Sci 63 (2006) 399-413
19. Ikonomidou C., Scheer I., Wilhelm T., Juengling F.D., Titze K., Stover B., et al. Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs. Eur J Paediatr Neurol 11 (2007) 297-301
20. Taniwaki T., Yamada T., Asahara H., Ohyagi Y., and Kira J. Ceramide induces apoptosis to immature cerebellar granule cells in culture. Neurochem Res 24 (1999) 685-690
21. Stoica B.A., Movsesyan V.A., Lea IV P.M., and Faden A.I. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci 22 (2003) 365-382
22. Willaime-Morawek S., Brami-Cherrier K., Mariani J., Caboche J., and Brugg B. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience 119 (2003) 387-397
23. Stoica B.A., Movsesyan V.A., Knoblach S.M., and Faden A.I. Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol Cell Neurosci 29 (2005) 355-371
24. Fariello R.G., Golden G.T., Smith G.G., and Reyes P.F. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res 3 (1989) 206-213
25. Clifford D.B., Olney J.W., Benz A.M., Fuller T.A., and Zorumski C.F. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia 31 (1990) 382-390
26. Fujikawa D.G., Daniels A.H., and Kim J.S. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res 17 (1994) 207-219
27. Fujikawa D.G. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 36 (1995) 186-195